atazanavir sulfate has been researched along with Complications, Infectious Pregnancy in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 18 (72.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badell, ML; Best, BM; Browning, R; Capparelli, EV; Chakhtoura, N; Denson, K; George, K; Mirochnick, M; Momper, JD; Paul, ME; Powis, KM; Rungruengthanakit, K; Shapiro, DE; Stek, A; Wang, J | 1 |
| Avelino-Silva, VI; Fonseca, FF; Pascom, ARP; Pereira, G; Perini, FB; Pinho, RGG | 1 |
| Bonito, A; Bonora, S; Calcagno, A; Casari, S; Castelli, F; D'Avolio, A; Di Perri, G; Domenighini, E; Focà, E; Quiros Roldan, E; Simiele, M; Trentini, L | 1 |
| Cetin, I; Dalzero, S; Degli Antoni, A; Floridia, M; Francisci, D; Frisina, V; Liuzzi, G; Maccabruni, A; Masuelli, G; Ravizza, M; Sansone, M; Simonazzi, G; Tamburrini, E; Tassis, B | 1 |
| Bonito, A; Bonora, S; Calcagno, A; Castelli, F; Castelnuovo, F; Cusato, J; D'Avolio, A; Di Perri, G; Domenighini, E; Focà, E; Quiros Roldan, E; Trentini, L | 1 |
| Bertz, R; Botes, M; Conradie, F; Eley, T; Hardy, H; Huang, SP; Josipovic, D; McGrath, D; Osiyemi, O; Zorrilla, CD | 1 |
| Atrio, JM; Chen, KT; Posada, R; Rodriguez Caprio, G; Sperling, RS | 1 |
| Degli Antoni, A; Fiscon, M; Floridia, M; Francisci, D; Giacomet, V; Liuzzi, G; Marconi, AM; Martinelli, P; Masuelli, G; Pinnetti, C; Ravizza, M; Spinillo, A; Tamburrini, E | 1 |
| Back, DJ; Brennan, M; Coulter-Smith, S; Else, LJ; Jackson, V; Khoo, SH; Lambert, JS | 1 |
| Anderson, J; Bradshaw, D; Brook, G; Byrne, L; Chan, SY; de Ruiter, A; Dhairyawan, R; Hawkins, D; Hay, P; Mandalia, S; Naftalin, C; Natha, M; Noble, H; Offodile, N; Perry, M; Poulton, M; Rodgers, M; Roedling, S; Samuel, M; Sarner, L; Shah, R; Short, CE; Smith, K; Taylor, G; Zhou, J | 1 |
| Bourgeois-Moine, A; Bourse, P; Calvez, V; Damond, F; Descamps, D; Dommergues, M; Duro, D; Faucher, P; Ichou, H; Landman, R; Lariven, S; Lê, MP; Legac, S; Mandelbrot, L; Matheron, S; Meier, F; Mortier, E; Peytavin, G; Soulié, C; Tubiana, R; Valantin, MA | 1 |
| Frederick, T; Hazra, R; Himes, SK; Huestis, MA; Huo, Y; Rice, ML; Siberry, GK; Sirois, PA; Williams, PL | 1 |
| Caniglia, EC; Hernán, MA; Hernandez-Diaz, S; Huo, Y; Jacobson, DL; Kapetanovic, S; Patel, K; Rich, KC; Seage, GR; Sirois, PA; Williams, PL | 1 |
| Barr, E; Davies, J; Forster, JE; Kinzie, K; Levin, MJ; McFarland, EJ; Pappas, J; Paul, S; Smith, C; Weinberg, A | 1 |
| Anceschi, MM; Ascenzi, P; Ivanovic, J; Mattia, E; Narciso, P; Nicastri, E; Notari, S; Pisani, G; Pucillo, LP; Signore, F; Tempestilli, M; Vallone, C | 1 |
| López-Cortés, LF | 1 |
| Antela López, A | 1 |
| Basar, M; Best, BM; Burchett, SK; Capparelli, EV; Hawkins, E; Hu, C; Mirochnick, M; Read, JS; Rossi, SS; Smith, E; Stek, AM | 1 |
| Azria, E; Crenn-Hebert, C; Ferreira, C; Floch-Tudal, C; Herinomenzanahary, E; Mandelbrot, L; Mazy, F; Meier, F; Peytavin, G; Treluyer, JM | 1 |
| Bertz, R; Botes, M; Child, M; Conradie, F; Eley, T; Hu, W; Josipovic, D; McGrath, D; Osiyemi, O; Vandeloise, E; Wirtz, V; Zorrilla, C | 1 |
| Albano, J; Arikan, D; Esker, S; Jimenez-Exposito, MJ; Seekins, D; Tilson, H; Uy, J | 1 |
| Best, BM; Burchett, SK; Byroads, M; Caparelli, E; Cressey, TR; Hawkins, E; Kreitchmann, R; Mirochnick, M; Rossi, S; Shapiro, DE; Smith, E; Stek, A; Wang, J; Watts, DH | 1 |
| Clarke, A; de Ruiter, A; Issa, R; Lechelt, M; Lyons, F; Magaya, V | 1 |
| Airoldi, M; Bertuletti, P; Cattaneo, D; Frigerio, L; Maggiolo, F; Ripamonti, D; Ruggeri, M; Suter, F | 1 |
2 review(s) available for atazanavir sulfate and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
[Pharmacology, pharmacokinetic features and interactions of atazanavir].
Topics: Anti-HIV Agents; Atazanavir Sulfate; Biological Availability; Biotransformation; Blood Proteins; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Fetal Blood; Glucuronosyltransferase; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Infant, Newborn; Kidney Diseases; Liver Diseases; Maternal-Fetal Exchange; Metabolic Clearance Rate; Molecular Structure; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pyridines | 2008 |
[Utility of atazanavir in special populations].
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardiovascular Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Emigrants and Immigrants; Female; Heroin Dependence; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperbilirubinemia, Neonatal; Infant; Infant, Newborn; Insulin Resistance; Kidney Diseases; Liver Diseases; Male; Methadone; Multicenter Studies as Topic; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyridines; Young Adult | 2008 |
5 trial(s) available for atazanavir sulfate and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; Female; Glucuronosyltransferase; HIV Infections; Humans; Hyperbilirubinemia; Infant, Newborn; Oligopeptides; Plasma; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyridines; Ritonavir | 2013 |
Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
Topics: Adenine; Anti-HIV Agents; Atazanavir Sulfate; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Oligopeptides; Organophosphonates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Treatment Outcome | 2011 |
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.
Topics: Adult; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Puerto Rico; Pyridines; Ritonavir; South Africa; United States; Viral Load | 2011 |
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Oligopeptides; Organophosphonates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Young Adult | 2013 |
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal-Fetal Exchange; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyridines; Ritonavir | 2007 |
18 other study(ies) available for atazanavir sulfate and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Child; Cobicistat; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Placenta; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies | 2022 |
Impact of antiretroviral regimen on viral suppression among pregnant women living with HIV in Brazil.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Brazil; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Raltegravir Potassium; Treatment Outcome; Viral Load | 2020 |
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients.
Topics: Adult; Atazanavir Sulfate; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Leukocytes, Mononuclear; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimesters; Prospective Studies; Ritonavir; RNA, Viral; Tenofovir; Viral Load | 2017 |
Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study.
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; Cholesterol; Darunavir; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Treatment Outcome; Triglycerides; Viral Load | 2018 |
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir.
Topics: Adult; Atazanavir Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver-Specific Organic Anion Transporter 1; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Pregnane X Receptor; Prospective Studies; Ritonavir | 2018 |
Maternal atazanavir usage in HIV-infected pregnant women and the risk of maternal and neonatal hyperbilirubinemia.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Female; HIV Infections; Humans; Hyperbilirubinemia; Infant, Newborn; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prevalence; Pyridines; Risk Assessment | 2013 |
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lipids; Liver Function Tests; Lopinavir; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyridines; RNA, Viral; Viral Load | 2014 |
Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Atazanavir Sulfate; Drug Monitoring; Female; HIV Infections; HIV Protease Inhibitors; Humans; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Ritonavir; Young Adult | 2014 |
Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; London; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Pyridines; Retrospective Studies; Viral Load | 2014 |
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.
Topics: Adult; Atazanavir Sulfate; CD4 Lymphocyte Count; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Female; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Viral Load | 2015 |
Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Chromatography, Liquid; Female; HIV Infections; Humans; Infant; Infant, Newborn; Language Development; Male; Maternal-Fetal Exchange; Meconium; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Pyridines; Tandem Mass Spectrometry | 2015 |
Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study.
Topics: Adult; Atazanavir Sulfate; Female; Fetal Development; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Infant, Newborn; Male; Nervous System; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Prospective Studies; Young Adult | 2016 |
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir.
Topics: Atazanavir Sulfate; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lopinavir; Male; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Ritonavir | 2016 |
[HIV infection and pregnancy. Improved therapy management for HIV infected pregnant patients].
Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Female; Germany; Guideline Adherence; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious | 2016 |
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apgar Score; Atazanavir Sulfate; Birth Weight; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Lopinavir; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Oligopeptides; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Pyrimidinones | 2009 |
Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia.
Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Bilirubin; Cohort Studies; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia, Neonatal; Infant, Newborn; Jaundice, Neonatal; Male; Maternal-Fetal Exchange; Medical Records; Oligopeptides; Phototherapy; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Pyridines; Retrospective Studies; Ritonavir | 2011 |
Monitoring the risk of birth defects associated with atazanavir exposure in pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anti-HIV Agents; Atazanavir Sulfate; Data Collection; Female; HIV Infections; Humans; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Pyridines; Registries; Retrospective Studies; Young Adult | 2012 |
Human placental transfer of atazanavir: a case report.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Female; HIV Infections; HIV Protease Inhibitors; Humans; Maternal-Fetal Exchange; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pyridines | 2006 |